Kuros Biosciences Financial Overview
Kuros Biosciences's market cap is currently CHF1.09B. The company's EPS TTM is CHF-0.052; its P/E ratio is -171.85; Kuros Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is CHF0.00. See an overview of income statement, balance sheet, and cash flow financials.
